 | | | | Related Healthscout Videos | |
|
Page: << Prev | 1 | 2 The one-year results from the study of 55 patients confirm earlier findings that most patients who receive the MitraClip experience only mild leakage after the device is installed.
"We earlier established that we could reduce mitral regurgitation with the MitraClip, and now we've established the durability of the result," Dr. Ted Feldman, director of the cardiac catheterization laboratory for Evanston Northwestern Healthcare in Illinois, said in a prepared statement.
"A large number of patients have had a good enough result that they've been able to delay or completely avoid surgery," Feldman said.
Text Continues Below
The third study concluded that an investigational drug called regadenoson appears to be better tolerated and better able to deliver high quality nuclear scan images of the heart than the widely-used adenosine.
The study found that regadenoson could be safely combined with mild exercise, which improves image quality.
"In nuclear cardiology, images are everything. Exercise improves blood flow to the heart instead of the gut, resulting in better images," Dr. Gregory Thomas, a clinical associate professor of medicine at the University of California, Irvine, and director of nuclear cardiology at Mission Internal Medical Group in Mission Viejo, said in a prepared statement.
The study compared the use of adenosine in patients who were lying on their backs during the scan and patients who received regadenoson and did mild exercise.
More information
The U.S. National Heart, Lung, and Blood Institute has more about heart and vascular diseases.
Page: << Prev | 1 | 2
-- Robert Preidt
|
.gif)
